NORBERT G RIEDEL Insider Trading $ARIA ARIAD PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NORBERT G RIEDEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NORBERT G RIEDEL. NORBERT G RIEDEL is Corporate Vice President in BAXTER INTERNATIONAL INC ($BAX) and Senior Vice President in BAXTER INTERNATIONAL INC ($BAX) and Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in Jazz Pharmaceuticals plc ($JAZZ) and CEO in Aptinyx Inc. ($APTX) and CEO and President in Aptinyx Inc. ($APTX) and Director in Eton Pharmaceuticals, Inc. ($ETON) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).
NORBERT G RIEDEL in ARIAD PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of NORBERT G RIEDEL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 16 2017
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NORBERT G RIEDEL in ARIAD PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APTX, ARIA, BAX, CERE, ETON, JAZZ
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 23.82 | 25,000 | 595,500 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 4.91 | 25,000 | 122,750 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 6.45 | 25,000 | 161,250 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 7.39 | 25,000 | 184,750 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | D | 8.50 | 25,000 | 212,500 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Sell | D | 0.00 | 139,867 | 0 | 0 | 139.9 K to 0 (-100.00 %) |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | A | 23.82 | 25,000 | 595,500 | 25,000 | |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 12,500 | 0 | 139,867 | 127.4 K to 139.9 K (+9.81 %) |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 5,508 | 0 | 127,367 | 121.9 K to 127.4 K (+4.52 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 12,500 | 0 | 121,859 | 109.4 K to 121.9 K (+11.43 %) |
Page: 1